NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/10/2023
Voltar para busca
Dado oficial do USPTO
ZOVYDD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ZOVYDD
ST13
US500000090534048Classe
1, 5, 42, 44
Pedido
90534048
Registro
7204292
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
31/10/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
18/02/2021
Data de registro
31/10/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/10/2023
Última transação
31/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
94
Localização do titular
TÜBINGEN, DE
Examinador
DEAN, JULES
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
C. S. (pessoa física)
CureVac AG
Representantes
Jennifer Fraser DYKEMA GOSSETT PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals and biological preparations being biomoleculesin particular biological macromoleculesfor industrial or scientific purposes; Reagents for research purposes; Peptide carrier molecules for association with a biological macromolecule being biological preparations for use in the pharmaceutical industry; Peptidic carrier molecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry; Peptide carrier molecule in combination with a biological macromolecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry
Classe 5
Chemical preparations for medical usefor therapeutic and prophylactic treatment of neurologicalneuromuscularneurodegenerativeinfectious and cardiovascular diseasesof autoimmune diseases and tumoursof allergiesof metabolic diseasesof heritable genetic diseasesfor therapies replacing proteins or enzymes; pharmaceutical preparationsimmunostimulantsin particular for human or veterinary medical purposes; pharmaceutical preparationsvaccinesin particular for human or veterinary medical purposes; pharmaceutical preparationsadjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromoleculesin particular for human or veterinary purposes for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment or prevention of infectious diseasesautoimmune diseases and tumoursfor treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy productsnucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical usein particular substances for food supplementsdietary food supplements; Vaccines; Vaccines for the prophylaxis of viral diseases
Classe 42
Scientific and technological servicesscientific researchanalysistesting in the field of biological moleculesin particular for identificationtesting and characterisation of biological molecules; scientific and technological servicesscientific pre-clinical and clinical testing of macromolecules in the field of biological molecules
Classe 44
Medical and veterinary servicesin particular for therapeutic and preventive treatment of tumour diseasesinfectious diseasesautoimmune disorders and allergiesfor treatment of inherited genetic diseases or for protein or enzyme replacement therapyfor treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor treatment of metabolic disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
31/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/08/2023
PUBO
PUBLISHED FOR OPPOSITION
15/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/07/2023
DOCK
ASSIGNED TO EXAMINER
20/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2023
ALIE
ASSIGNED TO LIE
08/06/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/03/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
21/02/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/01/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/01/2023
CNSI
SUSPENSION INQUIRY WRITTEN
11/01/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
30/11/2022
DOCK
ASSIGNED TO EXAMINER
28/11/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
21/11/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/04/2022
GNSL
LETTER OF SUSPENSION E-MAILED
08/04/2022
CNSL
SUSPENSION LETTER WRITTEN
08/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/03/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/09/2021
GNRT
NON-FINAL ACTION E-MAILED
16/09/2021
CNRT
NON-FINAL ACTION WRITTEN
16/09/2021
DOCK
ASSIGNED TO EXAMINER
13/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/05/2021
NWAP
NEW APPLICATION ENTERED
22/02/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZOVYDD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.